The Food and Drug Administration (FDA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) met on Tuesday to optimize the facilitated review pathway (FRP) to expedite access to essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback